Ronald Todd Plott is Director at Phio Pharmaceuticals Corp. (PHIO). They have made 2 open-market trades across 1 company since 2026, most recently 2026-09-29.
CIK 0001768337
2 open-market purchases totalling $27K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PHIO | 42,000 | $37K |
Shares reported on the most recent Form 4, priced at the 2026-09-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.